Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL-2)

Next Previous
Trial Profile

Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL-2)

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Jun 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Udenafil (Primary)
  • Indications Ventricular dysfunction
  • Focus Registrational; Therapeutic Use
  • Acronyms FUEL-2
  • Sponsors Mezzion

Most Recent Events

  • 11 Jun 2025 According to a Mezzion media release, company announced a major milestone in their clinical development program, having secured approximately $20 million USD in strategic funding to support the ongoing global Phase 3 FUEL-2 trial of udenafil for patients with Fontan circulation.
  • 01 Mar 2024 According to a Mezzion media release, currently, 22 sites in the U.S. are enrolling or will begin enrolling in the coming weeks.
  • 01 Mar 2024 According to a Mezzion media release, the company has announced Dr. Rahul Rathod, as the Global Principal Investigator of FUEL-2.He will lead the study analysis and contribute to reporting the results to the Food and Drug Administration (FDA).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top